These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 219434)

  • 1. Effects of naltrexone on mood and neuroendocrine function in normal adult males.
    Mendelson JH; Ellingboe J; Keuhnle JC; Mello NK
    Psychoneuroendocrinology; 1978 Oct; 3(3-4):231-6. PubMed ID: 219434
    [No Abstract]   [Full Text] [Related]  

  • 2. Naltrexone-induced dysphoria in former opioid addicts.
    Crowley TJ; Wagner JE; Zerbe G; Macdonald M
    Am J Psychiatry; 1985 Sep; 142(9):1081-4. PubMed ID: 2992300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of naloxone and naltrexone in different types of psychoses.
    Volavka J
    Mod Probl Pharmacopsychiatry; 1981; 17():202-12. PubMed ID: 6276726
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone.
    Schecter A
    Am J Drug Alcohol Abuse; 1980; 7(1):1-18. PubMed ID: 6254356
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic blockade of opiate receptors: influence on reproduction and body weight in female rats.
    Pfeiffer DG; Nikolarakis KE; Pfeiffer A
    Neuropeptides; 1984 Dec; 5(1-3):279-82. PubMed ID: 6099513
    [No Abstract]   [Full Text] [Related]  

  • 6. Nontolerance to the opioid antagonism of naltrexone.
    Kleber HD; Kosten TR; Gaspari J; Topazian M
    Biol Psychiatry; 1985 Jan; 20(1):66-72. PubMed ID: 2981129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heroin and naltrexone effects on pituitary-gonadal hormones in man: tolerance and supersensitivity.
    Mendelson JH; Ellingboe J; Kuehnle J; Mello NK
    NIDA Res Monogr; 1979; 27():302-8. PubMed ID: 121347
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists.
    Takemori AE; Portoghese PS
    Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment.
    Tempel A; Zukin RS; Gardner EL
    Life Sci; 1982 Sep 20-27; 31(12-13):1401-4. PubMed ID: 6292636
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of naloxone and naltrexone on locomotor activity in C57BL/6 and DBA/2 mice.
    Castellano C; Puglisi-Allegra S
    Pharmacol Biochem Behav; 1982 Apr; 16(4):561-3. PubMed ID: 6280203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of naloxone and naltrexone to antagonize halothane anesthesia in the dog.
    Pace NL; Wong KC
    Anesth Analg; 1979; 58(1):36-9. PubMed ID: 219728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone and naltrexone: actions and interactions at an opiate drug receptor on frog skeletal muscle fibers.
    Frank GB; Marwaha J
    J Pharmacol Exp Ther; 1979 Jun; 209(3):382-8. PubMed ID: 220407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate antagonists stimulate affiliative behaviour in monkeys.
    Fabre-Nys C; Meller RE; Keverne EB
    Pharmacol Biochem Behav; 1982 Apr; 16(4):653-9. PubMed ID: 6280208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-dimensional analyses of behavior in mice treated with naltrexone.
    Ukai M; Kameyama T
    Physiol Behav; 1985 Feb; 34(2):311-3. PubMed ID: 2987990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heroin and naltrexone effects on pituitary-gonadal hormones in man: interaction of steroid feedback effects, tolerance and supersensitivity.
    Mendelson JH; Ellingboe J; Kuehnle JC; Mello NK
    J Pharmacol Exp Ther; 1980 Sep; 214(3):503-6. PubMed ID: 7400959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone in the management of heroin addiction: critique of the rationale.
    Goldstein A
    NIDA Res Monogr; 1976 Sep; (9):158-61. PubMed ID: 187941
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of endogenous opioid blockade on the amplitude and frequency of pulsatile luteinizing hormone secretion in normal men.
    Ellingboe J; Veldhuis JD; Mendelson JH; Kuehnle JC; Mello NK
    J Clin Endocrinol Metab; 1982 Apr; 54(4):854-7. PubMed ID: 7061693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
    Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
    Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of prolactin release by endogenous opiates.
    Grandison L; Guidotti A
    Nature; 1977 Nov; 270(5635):357-9. PubMed ID: 201861
    [No Abstract]   [Full Text] [Related]  

  • 20. Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog.
    Vaupel DB
    Eur J Pharmacol; 1983 Sep; 92(3-4):269-74. PubMed ID: 6313397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.